{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:32Z","timestamp":1760060972040,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007239","name":"Los Angeles County Department of Public Health","doi-asserted-by":"publisher","award":["PH-002795"],"award-info":[{"award-number":["PH-002795"]}],"id":[{"id":"10.13039\/100007239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:17:57Z","timestamp":1510273077000},"page":"105-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up"],"prefix":"10.1016","volume":"85","author":[{"given":"Desir\u00e9e","family":"Cr\u00e8vecoeur-MacPhail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-8067","authenticated-orcid":false,"given":"Sarah J.","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-2498","authenticated-orcid":false,"given":"Loretta","family":"Denering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.11.004_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2015.10.003","article-title":"Extended-release naltrexone: A qualitative analysis of barriers to routine use","volume":"62","author":"Alanis-Hirsch","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.11.004_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1996.01830030047008","article-title":"The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies","volume":"53","author":"Anton","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2017.11.004_bb0015","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","article-title":"Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial","volume":"156","author":"Anton","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2017.11.004_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/alcalc\/agh073","article-title":"Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment","volume":"39","author":"Bottlender","year":"2004","journal-title":"Alcohol and Alcoholism"},{"key":"10.1016\/j.jsat.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4088\/JCP.v69n0204","article-title":"Early treatment response in alcohol dependence with extended-release naltrexone","volume":"69","author":"Ciraulo","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsat.2017.02.011","article-title":"The Los Angeles county hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010\u20132015)","volume":"85","author":"Cousins","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/08897077.2015.1052868","article-title":"A demonstration project implementing extended-release naltrexone in Los Angeles County","volume":"37","author":"Cousins","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/02791072.2007.10399899","article-title":"The rise in treatment admissions for primary methamphetamine use in Los Angeles County from 2001 through 2005","volume":"4","author":"Cr\u00e8vecoeur","year":"2007","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/02791072.2010.10400550","article-title":"Inside the black box: Measuring addiction treatment services and their relation to outcomes","volume":"6","author":"Cr\u00e8vecoeur-MacPhail","year":"2010","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn alcohol craving scale","volume":"23","author":"Flannery","year":"1999","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"4","key":"10.1016\/j.jsat.2017.11.004_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure","volume":"34","author":"Knudsen","year":"2011","journal-title":"Evaluation and Program Planning"},{"key":"10.1016\/j.jsat.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2008.07.001","article-title":"The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients","volume":"36","author":"Lapham","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jsat.2012.08.012","article-title":"Extended-release naltrexone plus medical management alcohol treatment in primary care: Findings at 15 months","volume":"43","author":"Lee","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.paid.2009.01.024","article-title":"Craving predicts within session drinking behavior following placebo","volume":"46","author":"Leeman","year":"2009","journal-title":"Personality and Individual Differences"},{"key":"10.1016\/j.jsat.2017.11.004_bb0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.03.055","article-title":"Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol dependent volunteers: A bold FMRI study","volume":"78","author":"Lukas","year":"2013","journal-title":"NeuroImage"},{"key":"10.1016\/j.jsat.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2015.04.009","article-title":"Medicaid coverage of medications to treat alcohol and opioid dependence","volume":"55","author":"Mark","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.11.004_bb0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.addbeh.2013.11.027","article-title":"Cue reactivity during treatment, and not impulsivity, predicts an initial lapse after treatment in alcohol use disorders","volume":"39","author":"Papachristou","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.jsat.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.amepre.2015.05.031","article-title":"2010 national and state costs of excessive alcohol consumption","volume":"49","author":"Sacks","year":"2015","journal-title":"American Journal of Preventive Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jsat.2017.11.004_bb0100","doi-asserted-by":"crossref","DOI":"10.5888\/pcd11.130293","article-title":"Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States","volume":"11","author":"Stahre","year":"2014","journal-title":"Preventing Chronic Disease"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:47Z","timestamp":1760039267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216304184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"alternative-id":["S0740547216304184"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.11.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}